🇺🇸 FDA
Patent

US 9046529

Prostatitis-associated antigens and methods of use thereof

granted A61KA61K2239/58A61K39/00

Quick answer

US patent 9046529 (Prostatitis-associated antigens and methods of use thereof) held by The Regents of the University of California expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2239/58, A61K39/00, A61K40/00, A61K40/11